{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:22:40Z","timestamp":1760548960352},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.braindev.2010.04.003","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T07:18:40Z","timestamp":1273043920000},"page":"189-194","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacokinetics and clinical application of intravenous valproate in Thai epileptic children"],"prefix":"10.1016","volume":"33","author":[{"given":"Anannit","family":"Visudtibhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasama","family":"Bhudhisawadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarin","family":"Vaewpanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvatna","family":"Chulavatnatol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sming","family":"Kaojareon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.braindev.2010.04.003_b0005","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/088307380502000101","article-title":"Treatment of pediatric epilepsy: expert opinion, 2005","volume":"20","author":"Wheless","year":"2005","journal-title":"J Child Neurol"},{"issue":"Suppl. 8","key":"10.1016\/j.braindev.2010.04.003_b0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1528-1167.2007.01349.x","article-title":"The use of valproate and new antiepileptic drugs in status epilepticus","volume":"48","author":"Trinka","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.04.003_b0015","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1528-1167.2008.01706_3.x","article-title":"The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus","volume":"49","author":"Shorvon","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.04.003_b0020","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1528-1167.2007.01465.x","article-title":"Aborted and refractory status epilepticus in children: a comparative analysis","volume":"49","author":"Lambrechtsen","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.04.003_b0025","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/01.WNL.0000142077.14142.AA","article-title":"Rapid infusion with valproate sodium is well tolerated in patients with epilepsy","volume":"63","author":"Wheless","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2010.04.003_b0030","first-page":"803","article-title":"Convulsive status epilepticus in Thai children at Ramathibodi Hospital","volume":"89","author":"Visudtibhan","year":"2006","journal-title":"J Med Assoc Thai"},{"issue":"Suppl.","key":"10.1016\/j.braindev.2010.04.003_b0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-0404.2007.00811.x","article-title":"Treatment of convulsive status epilepticus in infants and young children in Japan","volume":"186","author":"Sugai","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.braindev.2010.04.003_b0040","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.braindev.2010.04.003_b0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/archneur.1989.00520370015008","article-title":"Pharmacokinetics of valproate in adults after a single loading dose","volume":"46","author":"Giroud","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.braindev.2010.04.003_b0050","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ana.410380418","article-title":"Safety of intravenous valproate","volume":"38","author":"Devinsky","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2010.04.003_b0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00002826-199903000-00007","article-title":"Intravenous loading of valproate for epilepsy","volume":"22","author":"Naritoku","year":"1999","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.braindev.2010.04.003_b0060","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0920-1211(02)00187-0","article-title":"Safety and tolerance of rapidly infused Depacon. A randomized trial in subjects with epilepsy","volume":"52","author":"Ramsay","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2010.04.003_b0065","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.seizure.2005.01.002","article-title":"Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus \u2013 experience in 102 adult patients","volume":"14","author":"Peters","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2010.04.003_b0070","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1528-1167.2007.00989.x","article-title":"Safety of rapid intravenous loading of valproate","volume":"48","author":"Limdi","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.04.003_b0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/clpt.1993.5","article-title":"Valproic acid pharmacokinetics in children. IV. Effects of age and antiepileptic drugs on protein binding and intrinsic clearance","volume":"53","author":"Cloyd","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.braindev.2010.04.003_b0080","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0887-8994(03)00019-5","article-title":"Rapid infusion of sodium valproate in acutely ill children","volume":"28","author":"Birnbaum","year":"2003","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2010.04.003_b0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1535-7597.2003.03314.x","article-title":"The pharmacology of parenteral valproate","volume":"3","author":"Kanner","year":"2003","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.braindev.2010.04.003_b0090","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1177\/0883073807306248","article-title":"Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial","volume":"22","author":"Mehta","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2010.04.003_b0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.mjt.0000155113.89092.58","article-title":"Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children","volume":"13","author":"Panomvana Na Ayudhya","year":"2006","journal-title":"Am J Ther"},{"key":"10.1016\/j.braindev.2010.04.003_b0100","first-page":"359","article-title":"Status epilepticus in children. Experience with intravenous valproate. Update of treatment guidelines","volume":"29","author":"Campistol","year":"1999","journal-title":"Rev Neurol"},{"key":"10.1016\/j.braindev.2010.04.003_b0105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/088307389901400405","article-title":"Clinical experience of three pediatric and one adult case of spike-and-wave status epilepticus treated with injectable valproic acid","volume":"14","author":"Chez","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2010.04.003_b0110","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1345\/aph.18349","article-title":"Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus","volume":"33","author":"Hovinga","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.braindev.2010.04.003_b0115","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/088307380001501216","article-title":"Intravenous valproate dosing in neonates","volume":"15","author":"Alfonso","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2010.04.003_b0120","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1212\/WNL.54.11.2188-a","article-title":"Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus","volume":"54","author":"Uberall","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2010.04.003_b0125","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1046\/j.1528-1157.2003.41302.x","article-title":"Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures","volume":"44","author":"Yu","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.04.003_b0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pediatrneurol.2006.11.003","article-title":"Safety of rapid intravenous valproate infusion in pediatric patients","volume":"36","author":"Morton","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2010.04.003_b0135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1592\/phco.27.4.519","article-title":"Clinical utility of a continuous intravenous infusion of valproic acid in pediatric patients","volume":"27","author":"Taylor","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"Suppl.","key":"10.1016\/j.braindev.2010.04.003_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2006.00666.x","article-title":"Role of valproate across the ages. Treatment of epilepsy in children","volume":"184","author":"Aldenkamp","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.braindev.2010.04.003_b0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1528-1157.1982.tb05063.x","article-title":"The pharmacokinetics of valproic acid after oral and parenteral administration in healthy volunteers","volume":"23","author":"Nitsche","year":"1982","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2010.04.003_b0150","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003088-198815060-00002","article-title":"Clinical pharmacokinetics of valproic acid","volume":"15","author":"Zaccara","year":"1988","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.braindev.2010.04.003_b0155","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2710.2002.00440.x","article-title":"Population pharmacokinetics of intravenous valproic acid in Korean patients","volume":"27","author":"Park","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.braindev.2010.04.003_b0160","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/01.wnl.0000224880.35053.26","article-title":"Sodium valproate vs phenytoin in status epilepticus: a pilot study","volume":"67","author":"Misra","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2010.04.003_b0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0920-1211(02)00251-6","article-title":"Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsy","volume":"53","author":"Cloyd","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2010.04.003_b0170","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0887-8994(86)90047-0","article-title":"Valproic acid pharmacokinetics in children: III. Very high dosage requirements","volume":"2","author":"Kriel","year":"1986","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2010.04.003_b0175","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1111\/j.1468-1331.2006.01394.x","article-title":"Acute encephalopathy after intravenous administration of valproate in non-convulsive status epilepticus","volume":"13","author":"Embacher","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.braindev.2010.04.003_b0180","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/088307389901401211","article-title":"Intravenous valproate associated with significant hypotension in the treatment of status epilepticus","volume":"14","author":"White","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2010.04.003_b0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0920-1211(02)00252-8","article-title":"Oral\/intravenous maintenance dosing of valproate following intravenous loading: a simulation","volume":"53","author":"Dutta","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2010.04.003_b0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pediatrneurol.2007.11.003","article-title":"Intravenous levetiracetam in children with epilepsy","volume":"38","author":"Goraya","year":"2008","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2010.04.003_b0195","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.yebeh.2008.12.009","article-title":"Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy","volume":"14","author":"Kellinghaus","year":"2009","journal-title":"Epilepsy Behav"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760410000896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760410000896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:48:16Z","timestamp":1559072896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760410000896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0387760410000896"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2010.04.003","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}